A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay
Lung cancer (LC) is the most common cancer-related death globally, and many efforts have
been made to improve the patient care of LC patients, as well as the development of efficient …
been made to improve the patient care of LC patients, as well as the development of efficient …
Expression, regulation, and function of exosome‐derived miRNAs in cancer progression and therapy
B Li, Y Cao, M Sun, H Feng - The FASEB Journal, 2021 - Wiley Online Library
Exosomes are a novel class of intercellular signal modulators that contain a wide range of
molecules and deliver information between cells and tissues. MicroRNAs (miRNAs), a type …
molecules and deliver information between cells and tissues. MicroRNAs (miRNAs), a type …
[HTML][HTML] An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress
T Igarashi, M Mazevet, T Yasuhara, K Yano… - Nature …, 2023 - nature.com
Activation of the KRAS oncogene is a source of replication stress, but how this stress is
generated and how it is tolerated by cancer cells remain poorly understood. Here we show …
generated and how it is tolerated by cancer cells remain poorly understood. Here we show …
[HTML][HTML] Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell …
K Yang, W Zhang, L Zhong, Y Xiao, S Sahoo… - Cell Death & …, 2023 - nature.com
Lung cancer is the leading cause of cancer-related deaths worldwide. KRAS is the main
oncogenic driver in lung cancer that can be activated by gene mutation or amplification, but …
oncogenic driver in lung cancer that can be activated by gene mutation or amplification, but …
[HTML][HTML] Circulating microRNAs as potential biomarkers in pancreatic cancer—advances and challenges
AA Seyhan - International journal of molecular sciences, 2023 - mdpi.com
There is an urgent unmet need for robust and reliable biomarkers for early diagnosis,
prognosis, and prediction of response to specific treatments of many aggressive and deadly …
prognosis, and prediction of response to specific treatments of many aggressive and deadly …
[HTML][HTML] Relationship between Fusobacterium nucleatum, inflammatory mediators and microRNAs in colorectal carcinogenesis
MA Proença, JM Biselli, M Succi… - World journal of …, 2018 - ncbi.nlm.nih.gov
AIM To examine the effect of Fusobacterium nucleatum (F. nucleatum) on the
microenvironment of colonic neoplasms and the expression of inflammatory mediators and …
microenvironment of colonic neoplasms and the expression of inflammatory mediators and …
Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer
Cancer is amongst the deadliest and most disruptive disorders, having a much higher death
rate than other diseases worldwide. Human cancer rates continue to rise, thereby posing the …
rate than other diseases worldwide. Human cancer rates continue to rise, thereby posing the …
Recent progress of biosensors for the detection of lung cancer markers
Lung cancer is one of the most common cancers worldwide and the leading cause of death.
Early screening of lung cancer is exceptionally essential for later treatment. Abnormal lung …
Early screening of lung cancer is exceptionally essential for later treatment. Abnormal lung …
[HTML][HTML] Role of RASA1 in cancer: A review and update
Y Zhang, Y Li, Q Wang, B Su, H Xu… - Oncology …, 2020 - spandidos-publications.com
Ras p21 protein activator 1 (RASA1) is a regulator of Ras GDP and GTP and is involved in
numerous physiological processes such as angiogenesis, cell proliferation, and apoptosis …
numerous physiological processes such as angiogenesis, cell proliferation, and apoptosis …
[HTML][HTML] Oncogenic K-Ras suppresses global miRNA function
K-Ras frequently acquires gain-of-function mutations (K-Ras G12D being the most common)
that trigger significant transcriptomic and proteomic changes to drive tumorigenesis …
that trigger significant transcriptomic and proteomic changes to drive tumorigenesis …